Therapy decisions in leukemia. Bone Marrow Transplant 1992 Jan;9(1):5-10
Date
01/01/1992Pubmed ID
1543950Scopus ID
2-s2.0-0026585639 (requires institutional sign-in at Scopus site) 8 CitationsAbstract
Complex factors determine how physicians select between alternative therapies. We conducted a survey of 352 leukemia experts to determine consensus regarding optimal treatment for leukemia and to identify factors correlated with therapy decisions. The study evaluated both general treatment policies and recommendations for specific clinical situations. Responses of chemotherapy, allotransplant and autotransplant experts were compared. Although responses of these groups were similar for general treatment policies, recommendations for specific cases differed substantially. Interestingly, responses of the three groups to some clinical situations also differed from conclusions of several published studies examining these issues. These data suggest that experts may discount published results in favor of personal experiences, perceptions of the best treatment strategy (based on published data or not) or available resources.
Author List
Atkinson KA, Horowitz MM, Sobocinski KA, Rimm AA, Bortin MM, Gale RPAuthor
Mary M. Horowitz MD, MS Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdultAntineoplastic Agents
Bone Marrow Transplantation
Child
Decision Making
HLA Antigens
Histocompatibility Testing
Humans
Leukemia
Medical Oncology
Surveys and Questionnaires
Tissue Donors
